| Cultured human endothelial cells generate tissue factor in response to endotoxin. M Colucci, G Balconi, R Lorenzet, A Pietra, D Locati, MB Donati, ... The Journal of clinical investigation 71 (6), 1893-1896, 1983 | 651 | 1983 |
| Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. M Colucci, JA Paramo, D Collen The Journal of clinical investigation 75 (3), 818-824, 1985 | 556 | 1985 |
| Sepsis, thrombosis and organ dysfunction N Semeraro, CT Ammollo, F Semeraro, M Colucci Thrombosis research 129 (3), 290-295, 2012 | 392 | 2012 |
| Plasminogen activator inhibitor in the blood of patients with coronary artery disease. JA Paramo, M Colucci, D Collen, F Van de Werf British medical journal (Clinical research ed.) 291 (6495), 573, 1985 | 384 | 1985 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 346 | 1998 |
| Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation LO Mosnier, PAK von dem Borne, JCM Meijers, BN Bouma Thrombosis and haemostasis 80 (11), 829-835, 1998 | 297 | 1998 |
| Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients Y Vanrenterghem, T Lerut, L Roels, J Gruwez, P Michielsen, ... The Lancet 325 (8436), 999-1002, 1985 | 255 | 1985 |
| Tissue factor in health and disease N Semeraro, M Colucci Thrombosis and haemostasis 78 (07), 759-764, 1997 | 249 | 1997 |
| Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis M Colucci, BM Binetti, MG Branca, C Clerici, A Morelli, N Semeraro, ... Hepatology 38 (1), 230-237, 2003 | 213 | 2003 |
| Sepsis-associated disseminated intravascular coagulation and thromboembolic disease N Semeraro, CT Ammollo, F Semeraro, M Colucci Mediterranean journal of hematology and infectious diseases 2 (3), 2010 | 198 | 2010 |
| Tissue factor expression and metastatic potential of colorectal cancer C Shigemori, H Wada, K Matsumoto, H Shiku, S Nakamura, H Suzuki Thrombosis and haemostasis 80 (12), 894-898, 1998 | 178 | 1998 |
| Coagulopathy of acute sepsis N Semeraro, CT Ammollo, F Semeraro, M Colucci Seminars in thrombosis and hemostasis, 650-658, 2015 | 148 | 2015 |
| Evidence that cells from experimental tumours can activate coagulation factor X L Curatolo, M Colucci, AL Cambini, A Poggi, L Morasca, MB Donati, ... British Journal of Cancer 40 (2), 228-233, 1979 | 148 | 1979 |
| Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy A Mele, F Tancredi, L Romano, A Giuseppone, M Colucci, A Sangiuolo, ... The Journal of infectious diseases 184 (7), 905-908, 2001 | 140 | 2001 |
| Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition … P Gresele, S Momi, M Berrettini, GG Nenci, HP Schwarz, N Semeraro, ... The Journal of clinical investigation 101 (3), 667-676, 1998 | 134 | 1998 |
| Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues R Lorenzet, G Peri, D Locati, P Allavena, M Colucci, N Semeraro, ... | 130 | 1983 |
| Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells L Gesualdo, E Ranieri, R Monno, MR Rossiello, M Colucci, N Semeraro, ... Kidney international 56 (2), 461-470, 1999 | 128 | 1999 |
| Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor CT Ammollo, F Semeraro, F Incampo, N Semeraro, M Colucci Journal of Thrombosis and Haemostasis 8 (4), 790-798, 2010 | 116 | 2010 |
| Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation MW Mosesson Thrombosis and haemostasis 89 (01), 9-12, 2003 | 110 | 2003 |
| Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols) C Mauz-Körholz, R Junker, U Göbel, U Nowak-Göttl Thrombosis and haemostasis 83 (06), 840-843, 2000 | 108 | 2000 |
